SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amgen Presents Several Sub-Analyses at American Society for Bone and Mineral Research From the Ongoing Open-Label Extension Study of the Pivotal Phase 3 Prolia Fracture Trial